Comparing sarcopenia in early and established rheumatoid arthritis
Presence and Comparison of Sarcopenia in Early Rheumatoid Arthritis and Rheumatoid Arthritis
This study is trying to see if the length of time someone has rheumatoid arthritis affects their muscle health by comparing muscle strength and mass in people with early versus established arthritis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 48 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Kayseri City Hospital Government |
| Locations | 1 site (Kocasinan, Kayseri) |
| Trial ID | NCT06284200 on ClinicalTrials.gov |
What this trial studies
This observational study aims to compare the presence of sarcopenia in patients with early rheumatoid arthritis to those with established rheumatoid arthritis. A total of 48 participants will be evaluated, with 24 patients from each group, using criteria set by the European Working Group on Sarcopenia in Older People. Assessments will include hand grip strength, muscle mass measurement through Bioelectrical Impedance Analysis, and walking speed tests, alongside various demographic and clinical data. The study will help understand the impact of rheumatoid arthritis duration on muscle health.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with rheumatoid arthritis, either early (less than 1 year) or established.
Not a fit: Patients with other rheumatic diseases, malnutrition, or certain medical conditions such as recent surgeries or pregnancy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the management of sarcopenia in rheumatoid arthritis patients, potentially improving their quality of life.
How similar studies have performed: While the specific comparison of sarcopenia in early versus established rheumatoid arthritis may be novel, studies on sarcopenia in various chronic conditions have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion criteria for the early RA group: * To be diagnosed with RA according to the 2010 ACR (American Society for the Study of Rheumatism) / EULAR (European Association for the Study of Rheumatism) RA classification criteria * Being 18 years or older * Being followed up with a diagnosis of RA for less than 1 year (early RA) Inclusion criteria for the RA group: * To be diagnosed with RA according to the 2010 ACR (American Society for the Study of Rheumatism) / EULAR (European Association for the Study of Rheumatism) RA classification criteria * Being 18 years or older Exclusion Criteria: * Presence of other rheumatic disease * Presence of malnutrition * Recent surgical history, * Stroke history, * Pregnancy, * Presence of prosthesis or metal implant, * Presence of a pacemaker, * Patients over 140 kg
Where this trial is running
Kocasinan, Kayseri
- Health Sciences University, Kayseri Medicine Faculty — Kocasinan, Kayseri, Turkey (Recruiting)
Study contacts
- Study coordinator: Havva Talay Çaliş, Prof
- Email: htalaycalis@yahoo.com
- Phone: +905326874541
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.